About Clinical Design
Clinical Design is a company based in Truro (United Kingdom) founded in 2014 by Oliver Blackwell. Clinical Design has raised $7.03 million across 9 funding rounds from investors including Cornwall & Isles of Scilly Investment Fund. The company has 5 employees as of July 31, 2021. Clinical Design offers products and services including UTS, UTS-10 Cap, and UTS Digital Analyser. Clinical Design operates in a competitive market with competitors including Bright Uro, DNC Biotechnology, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others.
- Headquarter Truro, United Kingdom
- Employees 5 as on 31 Jul, 2021
- Founders Oliver Blackwell
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clinical Design Technologies Limited
- Date of Incorporation 28 Aug, 2014
- Jurisdiction NEWTON ABBOT, DEVON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.03 M (USD)
in 9 rounds
-
Latest Funding Round
$29.85 K (USD), Seed
Oct 09, 2023
- Investors
-
Employee Count
5
as on Jul 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinical Design
Clinical Design offers a comprehensive portfolio of products and services, including UTS, UTS-10 Cap, and UTS Digital Analyser.
Digital device for fast and accurate urinalysis at point of care
Single-use caps with reagent pads for 10 diagnostic parameters
Analyzer providing precise urine test results for healthcare use
People of Clinical Design
Unlock access to complete
Unlock access to complete
Funding Insights of Clinical Design
Clinical Design has successfully raised a total of $7.03M across 9 strategic funding rounds. The most recent funding activity was a Seed round of $29.85 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clinical Design
Clinical Design has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cornwall & Isles of Scilly Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided to SMEs in Cornwall and Isles of Scilly.
|
Locked | Locked | Locked |
Investor details for Clinical Design
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clinical Design
Investment portfolio details for Clinical Design
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clinical Design
Detailed financials for Clinical Design
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clinical Design Comparisons
Peer comparison for Clinical Design
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clinical Design
Clinical Design operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bright Uro, DNC Biotechnology, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic devices for lower urinary tract diseases are developed.
|
|
| Locked | Locked | Locked |
In vitro diagnostic devices for urine infection detection are developed.
|
|
| Locked | Locked | Locked |
Uro-flow meters for LUTS diagnosis and patient care are provided.
|
|
| Locked | Locked | Locked |
High-throughput clinical analyzers, microscopes, and glucometers are developed and manufactured.
|
|
| Locked | Locked | Locked |
Provides DIY test kits for benign prostatic hyperplasia (BPH).
|
Detailed competitors of Clinical Design
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clinical Design
Complete news archive for Clinical Design
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clinical Design
Clinical Design was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Clinical Design is headquartered in Truro, United Kingdom. It is registered at Truro, Cornwall, United Kingdom.
Oliver Blackwell is the current CEO of Clinical Design. They have also founded this company.
Clinical Design is a funded company, having raised a total of $7.03M across 9 funding rounds to date.
As of Jul 31, 2021, the latest employee count at Clinical Design is 5.
Developer of a urine diagnostic medical device. The company has developed a patented device called UTS-10 Cap which content the reagent pad to test ten parameters: leukocytes, nitrite, urobilinogen, protein, pH, blood, specific gravity, ketone, bilirubin, and glucose. The result is showed in the UTS digital analyzer which is connected to the UTS-10 Cap.
Clinical Design's top competitors include Bright Uro, DNC Biotechnology and Stream DX.
Clinical Design offers UTS, UTS-10 Cap, and UTS Digital Analyser.
Clinical Design has 1 investor. Key investors include Cornwall & Isles of Scilly Investment Fund.
The valuation of Clinical Design is $13.82M as of Jul 2021.